Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rasmus Søgaard Hansen1, Julie Brogaard Larsen2,3, Pernille Just Vinholt1,4

  • 1Blodprøver og Biokemi, Odense Universitetshospital.

Ugeskrift for Laeger
|June 7, 2024
PubMed
Summary

Antiphospholipid syndrome (APS) involves antibodies against phospholipid-binding proteins, increasing risks of blood clots and pregnancy issues. This review covers the 2023 classification criteria and management of APS.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness and safety of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome and venous thrombosis: A retrospective cohort study.

Thrombosis research·2026
Same author

Cyclooxygenase-1-Inhibition with Aspirin in Patients with Chronic Coronary Syndrome.

TH open : companion journal to thrombosis and haemostasis·2026
Same author

Association between Sex and Platelet Function in Patients with Diabetes Mellitus Type II: A Systematic Review.

Seminars in thrombosis and hemostasis·2026
Same author

Evaluation of AI-assisted chart review for acute myocardial infarction and cardiogenic shock.

Danish medical journal·2026
Same author

Can the Contact System be the Missing Link in Immune Checkpoint Inhibitors Associated Thromboinflammation?

Hamostaseologie·2026
Same author

Performance evaluation of the new Sysmex XR9000 hematology system in a clinical setting in comparison with Sysmex XN9100.

Scandinavian journal of clinical and laboratory investigation·2026

Area of Science:

  • Immunology
  • Rheumatology
  • Hematology

Background:

  • Antiphospholipid syndrome (APS) is characterized by antiphospholipid antibodies (aPL) targeting phospholipid-binding proteins.
  • APS significantly elevates the risk of thromboembolism and obstetric complications.
  • Understanding APS is crucial for managing associated health risks.

Approach:

  • This review summarizes the 2023 international classification criteria for APS.
  • It details the six clinical and two laboratory domains essential for diagnosis.
  • The review outlines current specialist approaches to APS diagnosis and treatment.

Key Points:

  • The 2023 criteria encompass venous, arterial, and microvascular events, obstetric issues, cardiac valve disease, and thrombocytopenia.

Related Experiment Videos

  • Laboratory confirmation requires lupus anticoagulant, anti-cardiolipin, or anti-β2-glycoprotein-I antibodies.
  • Accurate diagnosis relies on integrating clinical and laboratory findings.
  • Conclusions:

    • APS diagnosis and management require specialized medical expertise.
    • This review provides a comprehensive overview for clinicians.
    • Adherence to updated criteria ensures optimal patient care for APS.